Table of Content - Europe And Japan Allergy Immunotherapy Market

Immunotherapy is a preventive treatment for allergic reactions which are caused by substances such as grass pollens, house dust mites and bee venom. While providing immunotherapy treatment to patients, the dose of the drug is gradually increased to which the person is allergic. Immunotherapy also reduces the inflammation that characterizes rhinitis and asthma. Allergy shots, also known as subcutaneous immunotherapy (SCIT), is the most commonly used immunotherapy and this is the only treatment available that actually changes the immune system, making it possible to prevent development of new allergies and asthma.

Market Dynamics

Market players are involved in research and development activities for development of drugs for allergy immunotherapy and this is expected to drive growth of the Europe and Japan allergy immunotherapy market, over the forecast period. For instance, in May 2018, Stallergenes Greer, a biopharmaceutical company, announced positive results for its phase III clinical trial which was carried out, in order to evaluate the efficacy and safety of its sublingual allergy immunotherapy tablet STAGR320, for the treatment of house dust mite.

Key players are engaged in receiving approvals for their drugs, from the regulatory authorities and this is expected to drive growth of the Europe and Japan allergy immunotherapy market, over the forecast period. For instance, in November 2018, Stallergenes Greer, a biopharmaceutical company, received approval from the U.S. Food and Drug Administration (US FDA), for the extension of the indication for Oralair, for the treatment of patients with grass pollen-induced allergic rhinitis.

Moreover, in September 2018, Torii Pharmaceutical Co., Ltd. announced that Japan’s Ministry of Health, Labour and Welfare had approved the New Drug Application (NDA) for the Japanese cedar sublingual allergy immunotherapy (SLIT) tablet, i.e, CEDARCURE.

Key features of the study:

This report provides an in-depth analysis of the Europe and Japan allergy immunotherapy market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the Europe and Japan allergy immunotherapy market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Novartis International AG, Merck & Co., Inc., Aimmune Therapeutics, Inc., Regeneron Pharmaceuticals, Inc., HAL Allergy B.V., Stallergenes Greer, ALK-Abelló A/S, Allergy Therapeutics Plc, Torii Pharmaceutical Co., Ltd., DESENTUM OY
Insights from this report would allow marketers and management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The Europe and Japan allergy immunotherapy market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Europe and Japan allergy immunotherapy market

Detailed Segmentation:

Europe and Japan Allergy Immunotherapy Market, By Treatment:
- Subcutaneous Immunotherapy (SCIT)
- Sublingual Immunotherapy (SLIT)
Europe and Japan Allergy Immunotherapy Market, By Allergy Type:
- Allergy Rhinitis
- Allergy Asthma
- Pollen Allergies
  - Cedar
  - Birch
  - Oak
  - Others
- Pet Allergy
  - Cats
  - Dogs
  - Other Pets
- Birds Allergy
- Others
Europe and Japan Allergy Immunotherapy Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Europe and Japan Allergy Immunotherapy Market, By Region:
- Europe
  - By Country:
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Denmark
    - Sweden
    - Poland
    - Belgium
    - Netherlands
    - Russia
    - Rest of Europe
- Japan
Company Profiles
- Novartis International AG *
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Merck & Co., Inc.
- Aimmune Therapeutics, Inc.
- Regeneron Pharmaceuticals, Inc.
- HAL Allergy B.V.
- Stallergenes Greer
- ALK-Abelló A/S
- Allergy Therapeutics Plc
- Torii Pharmaceutical Co., Ltd.
- DESENTUM OY

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Overview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Treatment
  - Market Snippet, By Allergy Type
  - Market Snippet, By Distribution Channel
  - Market Snippet, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Regulatory Scenario
- PEST Analysis
- Recent Product Launch/Approval
- Epidemiology
- Mergers and Acquisitions
Europe and Japan Allergy Immunotherapy Market - Impact of Coronavirus (Covid-19) Pandemic
- Impact on Supply Chain
- Impact on Research and Development
- Government Initiatives
Europe and Japan Allergy Immunotherapy Market, By Treatment, 2017-2030 (US$ Million)
- Introduction
  - Market Share Analysis, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018 - 2030
  - Segment Trends
- Subcutaneous Immunotherapy (SCIT)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
- Sublingual Immunotherapy (SLIT)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Europe and Japan Allergy Immunotherapy Market, By Allergy Type, 2017 - 2030 (US$ Million)
- Introduction
  - Market Share Analysis, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018 - 2030
  - Segment Trends
- Allergy Rhinitis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
- Allergy Asthma
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
- Pollen Allergies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    - Cedar
    - Birch
    - Oak
    - Others
  - Pet Allergy
    - Introduction
    - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
      - Cats
      - Dogs
      - Other Pets
    - Birds Allergy
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    - Others
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Europe and Japan Allergy Immunotherapy Market, By Distribution Channel, 2017 - 2030 (US$ Million)
- Introduction
  - Market Share Analysis, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018 - 2030
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Europe and Japan Allergy Immunotherapy Market, By Region, 2017 - 2030 (US$ Million)
- Introduction
  - Market Share Analysis, By Region, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, For Regions, 2018 - 2030
  - Regional Trends
- Europe
  - Market Size and Forecast, By Treatment, 2017 - 2030 (US$ Mn)
  - Market Size and Forecast, By Allergy Type, 2017 - 2030 (US$ Mn)
  - Market Size and Forecast, By Distribution Channel, 2017 - 2030 (US$ Mn)
  - Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Denmark
    - Sweden
    - Poland
    - Belgium
    - Netherlands
    - Russia
    - Rest of Europe
  - Japan
    - Market Size and Forecast, By Treatment, 2017 - 2030 (US$ Mn)
    - Market Size and Forecast, By Allergy Type, 2017 - 2030 (US$ Mn)
    - Market Size and Forecast, By Distribution Channel, 2017 - 2030 (US$ Mn)
Competitive Landscape
- Company Profiles
  - Novartis International AG
    - Company Overview
    - Drug Portfolio
    - Financial Performance
    - Recent Developments/Updates
    - Strategies
  - Merck & Co., Inc.
    - Company Overview
    - Drug Portfolio
    - Financial Performance
    - Recent Developments/Updates
    - Strategies
  - Aimmune Therapeutics, Inc.
    - Company Overview
    - Drug Portfolio
    - Financial Performance
    - Recent Developments/Updates
    - Strategies
  - Regeneron Pharmaceuticals, Inc.
    - Company Overview
    - Drug Portfolio
    - Financial Performance
    - Recent Developments/Updates
    - Strategies
  - HAL Allergy B.V.
    - Company Overview
    - Drug Portfolio
    - Financial Performance
    - Recent Developments/Updates
    - Strategies
  - Stallergenes Greer
    - Company Overview
    - Drug Portfolio
    - Financial Performance
    - Recent Developments/Updates
    - Strategies
  - ALK-Abelló A/S
    - Company Overview
    - Drug Portfolio
    - Financial Performance
    - Recent Developments/Updates
    - Strategies
  - Allergy Therapeutics Plc
    - Company Overview
    - Drug Portfolio
    - Financial Performance
    - Recent Developments/Updates
    - Strategies
  - Torii Pharmaceutical Co., Ltd.
    - Company Overview
    - Drug Portfolio
    - Financial Performance
    - Recent Developments/Updates
    - Strategies
  - DESENTUM OY
    - Company Overview
    - Drug Portfolio
    - Financial Performance
    - Recent Developments/Updates
    - Strategies
- Analyst Views
Section
- References
- Research Methodology
- About us and Sales Contact

*Browse 45 market data tables and 39 figures on "Europe and Japan Allergy Immunotherapy Market” - Forecast to 2030.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

Need a Custom Report?

EXISTING CLIENTELE